What fluorescence in situ hybridisation (FISH) abnormality is associated with mantle cell lymphoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

FISH Mutation Associated with Mantle Cell Lymphoma

The hallmark FISH abnormality in mantle cell lymphoma is t(11;14)(q13;q32), which results in CCND1-IGH gene fusion and subsequent cyclin D1 overexpression 1.

Primary Diagnostic Abnormality

The t(11;14)(q13;q32) translocation is the defining genetic feature of MCL and should be detected by FISH testing in the diagnostic work-up 1. This translocation:

  • Occurs in approximately 96% of MCL cases 2
  • Results in juxtaposition of the CCND1 gene on chromosome 11 with the immunoglobulin heavy chain (IGH) locus on chromosome 14
  • Leads to constitutive overexpression of cyclin D1 protein

FISH for t(11;14) is specifically recommended in the diagnostic algorithm, particularly in leukemic cases where flow cytometry shows CD5+/CD19/20+ immunophenotype 1. This testing can be performed on bone marrow samples, lymph node tissue, or peripheral blood.

Secondary Cytogenetic Abnormalities

Beyond the primary t(11;14), additional FISH abnormalities are detected in approximately 54% of MCL cases and carry important prognostic implications 2:

High-Risk Secondary Abnormalities:

  • TP53 deletions (17p13) - associated with aggressive disease and poor prognosis 1, 3
  • CDKN2A deletions (9p21) - marker of adverse biology 2
  • MYC rearrangements - associated with blastoid variants and inferior outcomes 2
  • ATM abnormalities - linked to more aggressive disease behavior 2

An expanded FISH panel including MYC, CDKN2A, TP53, and ATM should be considered in cases with blastoid morphology or anomalous immunohistochemistry expression 2. Complex karyotypic alterations detected by comprehensive FISH are associated with higher proliferation indices and inferior prognosis 3.

Clinical Caveats

  • Rare cyclin D1-negative MCL exists: In the uncommon CD5-negative MCL cases, FISH may not detect CCND1 breaks 4
  • IgH/CCND1 polyploidy can occur in classic cases, representing a variant pattern 4
  • FISH is distinctly more sensitive than classical cytogenetic banding analysis for detecting these abnormalities 3
  • In atypical presentations mimicking chronic lymphocytic leukemia (CLL score of 4), interphase FISH for t(11;14) plays a critical diagnostic role in distinguishing MCL from CLL 5

The detection of t(11;14) by FISH, combined with cyclin D1 immunohistochemistry, provides the most reliable diagnostic confirmation of MCL 1, 6.

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.